Ligand profile
CEP
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_03128 — Beta-lactamase CTX-M-2
Identifiers
Database identifiers and provenance.
- Ligand ID
CEP- PDB
1iyp- UniProt (similar protein)
Q47066- Target protein
- KP13_03128
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 121.8
- −1 ≤ LogP ≤ 5 0.54
- MW ≤ 500 Da 398.5
- LogP ≤ 5 0.54
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 121.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COC(=O)CC1=C(N[C@H](SC1)[C@@H](C=O)NC(=O)Cc2cccs2)C(=O)OCOC(=O)CC1=C(N[C@H](SC1)[C@@H](C=O)NC(=O)Cc2cccs2)C(=O)O
InChI=1S/C16H18N2O6S2/c1-24-13(21)5-9-8-26-15(18-14(9)16(22)23)11(7-19)17-12(20)6-10-3-2-4-25-10/h2-4,7,11,15,18H,5-6,8H2,1H3,(H,17,20)(H,22,23)/t11-,15-/m1/s1InChI=1S/C16H18N2O6S2/c1-24-13(21)5-9-8-26-15(18-14(9)16(22)23)11(7-19)17-12(20)6-10-3-2-4-25-10/h2-4,7,11,15,18H,5-6,8H2,1H3,(H,17,20)(H,22,23)/t11-,15-/m1/s1
UUWFGEKEQSCSMB-IAQYHMDHSA-NUUWFGEKEQSCSMB-IAQYHMDHSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00905' 'PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand CEP →
- PDB RCSB structure 1iyp →
- UniProt UniProt Q47066 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CEP”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03128.
PDB 51
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 6
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).